Hydroxychloroquine for sale at a pharmacy in France. | Marc Piasecki/Getty Images

A growing body of research finds the antimalarial doesn’t help hospitalized coronavirus patients.

Does President Trump’s favored coronavirus treatment, the antimalarial drug hydroxychloroquine, make you more likely to die of Covid-19? That was the finding in a recent study published in the medical journal The Lancet. The study looked at more than 96,000 coronavirus patients across the world and found that, after controlling for age, sex, and how sick the patients were, patients receiving hydroxychloroquine or a variant were about twice as likely to die as those who did not.

The result quickly made headlines in top papers, may have spurred the World Health Organization to discontinue the use of hydroxychloroquine in an ongoing drug trial, and may change the way tens of thousands of coronavirus patients worldwide are treated